Moomoo AI 已提取核心信息
Granahan Investment Management LLC, an investment adviser based in Massachusetts, has filed a Schedule 13G with the Securities and Exchange Commission on February 14, 2024, indicating a significant stake in bluebird bio, Inc. As of December 31, 2023, Granahan Investment Management reported beneficial ownership of 8,077,697 shares of bluebird bio's common stock, representing 7.38% of the company's class. The filing, made under Rule 13d-1(b), shows that Granahan has sole voting power over 6,741,868 shares and sole dispositive power over all 8,077,697 shares. The investment firm has declared that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of bluebird bio.
Granahan Investment Management LLC, an investment adviser based in Massachusetts, has filed a Schedule 13G with the Securities and Exchange Commission on February 14, 2024, indicating a significant stake in bluebird bio, Inc. As of December 31, 2023, Granahan Investment Management reported beneficial ownership of 8,077,697 shares of bluebird bio's common stock, representing 7.38% of the company's class. The filing, made under Rule 13d-1(b), shows that Granahan has sole voting power over 6,741,868 shares and sole dispositive power over all 8,077,697 shares. The investment firm has declared that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of bluebird bio.
总部位于马萨诸塞州的投资顾问格拉纳汉投资管理有限责任公司已于2024年2月14日向美国证券交易委员会提交了附表13G，表明蓝鸟生物公司拥有大量股份。截至2023年12月31日，格拉纳汉投资管理公司报告了蓝鸟生物普通股8,077,697股的实益所有权，占该公司类别的7.38％。该文件是根据第13d-1（b）条提交的，显示格拉纳汉对6,741,868股股票拥有唯一的投票权，对所有8,077,697股股票拥有唯一的处置权。该投资公司宣布，这些股票是在正常业务过程中收购的，不是为了改变或影响蓝鸟生物的控制权。
总部位于马萨诸塞州的投资顾问格拉纳汉投资管理有限责任公司已于2024年2月14日向美国证券交易委员会提交了附表13G，表明蓝鸟生物公司拥有大量股份。截至2023年12月31日，格拉纳汉投资管理公司报告了蓝鸟生物普通股8,077,697股的实益所有权，占该公司类别的7.38％。该文件是根据第13d-1（b）条提交的，显示格拉纳汉对6,741,868股股票拥有唯一的投票权，对所有8,077,697股股票拥有唯一的处置权。该投资公司宣布，这些股票是在正常业务过程中收购的，不是为了改变或影响蓝鸟生物的控制权。
有用
没用